Weekly Life Science News Round Up: 6th – 10th June

A round-up of the latest news from the Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Devices sectors from 6^th-10^th June.

Cambridge Pharma opens on the Cambridge Research Park offering pharmaceutical development services in a world class facility

SMC Ltd., a leading solutions provider in the manufacturing of pharmaceutical and medical devices, announces the opening of Cambridge Pharma, a new business offering pharmaceutical development services, including sterile fill-finish.

Kinarus Therapeutics announces name change and commences trading on the SIX Swiss exchange under ticker ‘KNRS’

Kinarus Therapeutics Holding AG announces that it has changed its name and that trading of its shares on the SIX Swiss exchange will continue under the new ticker symbol KNRS.

Coave Therapeutics and ABL enter into strategic collaboration to develop gene therapy manufacturing processes and create joint capabilities for process development of AAV-based gene therapy

Coave Therapeutics and ABL announce that they have entered into a strategic collaboration to develop gene therapy manufacturing processes. The financial terms are not disclosed.

WittKieffer Life Sciences Practice expands global capabilities

WittKieffer, a leading global executive search and advisory firm dedicated to improving quality of life through impactful leadership, announces the expansion of its global Life Sciences Practice with the addition of three experienced consultants.

Worldwide Clinical Trials opens multimillion dollar Bioanalytical Center of Excellence supporting early phase development

Worldwide Clinical Trials announces that it has expanded its early phase clinical trial capabilities by opening its Bioanalytical Center of Excellence – a larger state-of-the-art lab in Austin, Texas.

Thermo Fisher Scientific’s clinical research business named Clinical Research Company of the Year for third consecutive year

The PPD clinical research business of Thermo Fisher Scientific has been named Clinical Research Company of the Year at the 2022 PharmaTimes Clinical Researcher of the Year international competition held recently in London.

Sanofi launches its first Digital Accelerator fueled by new talent and focused on growth

Sanofi announces the launch of its first Digital Accelerator to foster its ambition to become a leading digital healthcare company.

Entos Pharmaceuticals expands R&D operations into the US

Entos Pharmaceuticals announces the opening of its new 9,600 square foot research and development facility in the Torrey Pines community of San Siego, California.

EVERSANA™ Unveils EVERSANA INTOUCH, a next-generation agency network delivering award-winning creative, digital, and global market access solutions for Life Sciences

EVERSANA™, unveils EVERSANA INTOUCH, marking the transformation of its full-service, global healthcare agency network serving the life sciences industry.

Coriolis Pharma invests in growth by creating a new campus in Martinsried-Munich

Coriolis Pharma is expanding its current headquarters to form a new Campus as the next step in its growth strategy. Located in the heart of the Biotech Hotspot Martinsried, the new Coriolis Campus will double the overall capacities to 14,000 sqm.

Innovative Trials to help fund research into multiple sclerosis through charity partnership

Innovative Trials, a UK-based clinical trials patient recruitment company, has announced its intention to help fund research into multiple sclerosis (MS) and contribute towards the MS Society’s vision of a world free from the effects of MS.

Serotiny announces a research collaboration with Janssen to optimise designs for Chimeric Antigen Receptors signalling domains

Serotiny announces a collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to optimise CAR designs for cellular therapy.

Pfizer to invest $120 million to produce COVID-19 oral treatment in the U.S.

Pfizer announces that it will further strengthen its commitment to United States manufacturing with a $120 million investment at its Kalamazoo, Michigan, facility, enabling U.S.-based production in support of its COVID-19 oral treatment, PAXLOVID TM.

NHS Chief receives CBE

Chief Executive of the NHS Business Services Authority (NHSBSA), Michael Brodie, has been awarded a CBE for services to health, particularly during the pandemic, in the Queen’s Birthday Honours list 2022.

MMS Holdings announces partnership with Medidata to provide Medidata’s advanced Rave EDC and decentralised clinical trial solutions to sponsors

MMS Holdings is pleased to announce a strategic partnership with Medidata, a Dassault Systèmes company, to provide clients a full range of solutions for clinical data management (CDM) and decentralised clinical trial (DCT) technologies, including Medidata’s unified platform and Rave EDC (Electronic Data Capture).